One vision —
a cancer-free future.
Unlike surgery, chemotherapy and radiation, cell and gene therapies harness the power of your immune system to destroy cancer cells without harming healthy tissue. We fund the research that will make this vision a reality.
Advancing cell and gene therapy research for childhood cancers
ACGT has been committed for more than 20 years to advancing new therapies for children with cancer.
FAQs about cell and gene therapy: Top questions and answers
Here are some of the top questions about cancer cell and gene therapy, along with the answers.
ACGT awards research grant for oncolytic virus to treat glioblastoma
Dr. Juan Fueyo, of MD Anderson Cancer Center, is working to improve the effectiveness of an oncolytic virus.
Photos from the 2023 Swim Across America Fairfield County Open Water Swim
The event is still bringing in donations and raising money to benefit ACGT and support cell and gene therapy research.
Our direct impact on eradicating all cancer.
Collaborating with partners and funding research fellows, we are transforming cancer treatments today while bringing the world closer to a cure for all cancers tomorrow.
34.2
million dollars awarded to groundbreaking research.
63
research fellows awarded grants.
38
top medical institutions funded.
Join forces with the world’s leading researchers to finally identify cures.
Cell and gene therapies harness the power of a patient’s own immune system to destroy cancer cells without harming healthy tissue.
Juan Fueyo, MD
MD Anderson Cancer Center
ACGT is funding research that uses an oncolytic virus to fight glioblastoma, a deadly type of brain tumor.
Hideho Okada, MD, PhD
University of California San Francisco
ACGT is funding a new clinical trial for children with a rare brain cancer.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Juan Fueyo, MD
MD Anderson Cancer Center
ACGT is funding research that uses an oncolytic virus to fight glioblastoma, a deadly type of brain tumor.
Hideho Okada, MD, PhD
University of California San Francisco
ACGT is funding a new clinical trial for children with a rare brain cancer.
Crystal Mackall, MD
Stanford University
Training CAR T cells to find and kill cancers that express the GD2 biomarker, including osteosarcoma, pediatric neuroblastoma and diffuse intrinsic pontine glioma.
Stephen Gottschalk, MD
St. Jude Children’s Research Hospital
Fortifying a patient’s immune system to attack and destroy sarcomas along with the blood vessels that support their growth.
Stay up-to-date with us and get involved.
Oct 05, 2022
100% of your donation will advance research to cure all cancers.
Your donation will help develop radical new cell and gene therapies that leverage the body’s own biology and immune system to control and ultimately eradicate cancer. 100% of donations directly support scientists working on breakthrough cancer cell and gene therapy research.
Donate Today